[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Citicoline Market, 2020-2026

October 2020 | 96 pages | ID: G9AC2694E5B6EN
Gen Consulting Company

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Citicoline, also known as cytidine diphosphate-choline or cytidine 5'-diphosphocholine is an intermediate in the generation of phosphatidylcholine from choline, a common biochemical process in cell membranes. Citicoline is used for Alzheimer's disease and other types of dementia, head trauma, cerebrovascular disease such as stroke, age-related memory loss, Parkinson's disease, attention deficit-hyperactive disorder (ADHD), and glaucoma. According to Gen Consulting Company, global citicoline market is projected to grow at a CAGR of 5.2% during the forecast period 2020-2026.

The report offers a breakdown of market shares by product, including Citicoline Free-base, Citicoline Sodium Salt. By application, the citicoline market is classified into Pharmaceutical, Food & Beverages. On the basis of region, the citicoline industry is analyzed across North America, Europe, Asia-Pacific, South America and MEA (the Middle East, and Africa).
By Product:
  • Citicoline Free-base
  • Citicoline Sodium Salt

By Application:
  • Pharmaceutical
  • Food & Beverages
By region, the market is analyzed across North America, Asia Pacific, Europe, Middle East & Africa and South America. This report forecasts revenue growth at global, regional & country level from 2020 to 2026.
  • North America (U.S., Canada, Mexico, etc.)
  • Asia-Pacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.)
  • Europe (Germany, UK, France, Italy, Russia, Spain, etc.)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.)
  • South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.)
The market research report covers the analysis of key stake holders of the citicoline market. Some of the leading players profiled in the report include:
  • Acharya Group
  • Bajaj Healthcare Ltd.
  • Euticals S.p.A.
  • Ferrer Internacional S.A.
  • Kaiping Qianniu Biochemical. Pharmaceutical Co., Ltd.
  • Kyowa Hakko Bio Co., Ltd.
  • SeQuent Scientific Limited
  • Suzhou Tianma Specialty Chemicals Co., Ltd.
  • TUOXIN Pharmaceutical Co,. Ltd.
*list is not exhaustive, request free sample to get a complete list of companies

The base year of the study is 2019, and forecasts run up to 2026.

Research Objective
  • To analyze and forecast the market size of global citicoline market.
  • To classify and forecast global citicoline market based on product, application.
  • To identify drivers and challenges for global citicoline market.
  • To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global citicoline market.
  • To conduct pricing analysis for global citicoline market.
  • To identify and analyze the profile of leading players operating in global citicoline market.
The report is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities. Key target audience are:
  • Manufacturers of citicoline
  • Raw material suppliers
  • Market research and consulting firms
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to citicoline
PART 1. INTRODUCTION

1.1 Market Definition
1.2 Key Benefit
1.3 Market Segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market Size and Forecast
4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
4.4 Impact of COVID-19 Pandemic on Global Economy
4.5 Porter's Five Forces Analysis
  4.5.1 Bargaining Power of Suppliers
  4.5.2 Bargaining Power of Consumers
  4.5.3 Threat of New Entrants
  4.5.4 Threat of Substitute Products and Services
  4.5.5 Degree of Competition

PART 5. GLOBAL MARKET FOR CITICOLINE BY PRODUCT

5.1 Market Overview
5.2 Citicoline Free-base
  5.2.1 Market Size and Forecast
5.3 Citicoline Sodium Salt
  5.3.1 Market Size and Forecast

PART 6. GLOBAL MARKET FOR CITICOLINE BY APPLICATION

6.1 Market Overview
6.2 Pharmaceutical
  6.2.1 Market Size and Forecast
6.3 Food & Beverages
  6.3.1 Market Size and Forecast

PART 7. GLOBAL MARKET FOR CITICOLINE BY GEOGRAPHY

7.1 Overview
  7.1.1 Market Size and Forecast
7.2 North America
  7.2.1 Market Size and Forecast
  7.2.2 North America: Citicoline Market by Country
    7.2.2.1 United States
    7.2.2.2 Canada
    7.2.2.3 Mexico
7.3 Europe
  7.3.1 Market Size and Forecast
  7.3.2 Europe: Citicoline Market by Country
    7.3.2.1 Germany
    7.3.2.2 France
    7.3.2.3 United Kingdom
    7.3.2.4 Italy
    7.3.2.5 Rest of The Europe
7.4 Asia-Pacific
  7.4.1 Market Size and Forecast
  7.4.2 Asia-Pacific: Citicoline Market by Country
    7.4.2.1 China
    7.4.2.2 India
    7.4.2.3 Japan
    7.4.2.4 South Korea
    7.4.2.5 ASEAN Countries
7.5 Middle East and Africa (MEA)
  7.5.1 Market Size and Forecast
  7.5.2 MEA: Citicoline Market by Country
    7.5.2.1 Saudi Arabia
    7.5.2.2 South Africa
    7.5.2.3 Turkey
7.6 South America
  7.6.1 Market Size and Forecast
  7.6.2 South America: Citicoline Market by Country
    7.6.2.1 Brazil
    7.6.2.2 Argentina
    7.6.2.3 Rest of South America

PART 8. COMPETITIVE LANDSCAPE

8.1 Market Share
8.2 Mergers & Acquisitions, Agreements, Collaborations and Partnerships

PART 9. KEY COMPETITOR PROFILES

9.1 Acharya Group
9.2 Bajaj Healthcare Ltd.
9.3 Euticals S.p.A.
9.4 Ferrer Internacional S.A.
9.5 Kaiping Qianniu Biochemical. Pharmaceutical Co., Ltd.
9.6 Kyowa Hakko Bio Co., Ltd.
9.7 SeQuent Scientific Limited
9.8 Suzhou Tianma Specialty Chemicals Co., Ltd.
9.9 TUOXIN Pharmaceutical Co,. Ltd.
*LIST IS NOT EXHAUSTIVE

PART 10. PATENT ANALYSIS

10.1 Patent Statistics
10.2 Regional Analysis
10.3 Trends Analysis

DISCLAIMER
ABOUT GEN CONSULTING COMPANY


More Publications